Genenta Science S.p.A. GNTA
Set alert
0.87 USD +0.04 +5.26%
As of Nov 3, 12:48 PM ET
0.8189 Day range 0.92
0.55 52-week range 2.62
- YTD
- -41.44%
- 1 year
- -65.91%
- Open
- 0.8359
- Prev close
- 0.829
- Mkt cap
- 42.07M
- Vol
- 179.65K
- Avg vol
- 77.01K
- EPS
- -0.37
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.8189
- High
- 0.92
- Forward P/E
- -7.53
- Beta
- 0.74
- Short ratio
- 0.19
- Inst. own
- 7.78%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 5.18
- 200-d avg
- 4.10
- 1y target
- 21.65
MAX chart
Events in this range
- Jan 13, 2022Rating: Maxim Group · — → Buy
- Jul 25, 2022Rating: HC Wainwright & Co. · — → Buy
- Jan 5, 2023Rating: EF Hutton · — → Buy
- Feb 8, 2023Rating: HC Wainwright & Co. · — → Buy
- May 13, 2024Rating: HC Wainwright & Co. · Buy → Buy
- Oct 2, 2024Rating: HC Wainwright & Co. · Buy → Buy
Signals (88)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Nov 2, 2026 | 1 day ago |
| SMA: Bearish | Aug 24, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 24, 2026 | 2 months ago |
| SMA: Bearish | Jul 27, 2026 | 3 months ago |
| SMA: Bullish | Jun 1, 2026 | 5 months ago |
| SMA: Bullish | May 25, 2026 | 5 months ago |
| MACD: Buy Signal | Mar 9, 2026 | 7 months ago |
| MACD: Sell Signal | Nov 3, 2025 | 1 year ago |
| SMA: Bearish | Oct 27, 2025 | 1 year ago |
| SMA: Bearish | Oct 27, 2025 | 1 year ago |
| SMA: Bullish | Oct 20, 2025 | 1 year ago |
| SMA: Bullish | Oct 20, 2025 | 1 year ago |
| MACD: Buy Signal | Oct 20, 2025 | 1 year ago |
| RSI: Overbought | Oct 20, 2025 | 1 year ago |
| SMA: Bearish | Sep 1, 2025 | 1 year ago |
| MACD: Sell Signal | Sep 1, 2025 | 1 year ago |
| SMA: Bullish | Aug 25, 2025 | 1 year ago |
| MACD: Buy Signal | Aug 25, 2025 | 1 year ago |
| SMA: Bearish | Aug 11, 2025 | 1 year ago |
| MACD: Sell Signal | Aug 11, 2025 | 1 year ago |
Newest 20 of 88.
Financial health
Altman Z-Score
-1.71 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
1 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C2 / 5 overall
- DCF 1
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 3
- P/E 1
- P/B 4
Valuation
P/E -3.8×
FY 2019 5y median -8.6× FY 2025
P/S 0.0×
FY 2019 5y median 0.0× FY 2025
P/B 1.1×
FY 2019 5y median 4.0× FY 2025
P/FCF -3.6×
FY 2019 5y median -12.3× FY 2025
EV/EBITDA -4.6×
FY 2019 5y median -7.7× FY 2025
EV/Sales 0.0×
FY 2019 5y median 0.0× FY 2025
FCF Yield -27.5%
FY 2019 5y median -8.1% FY 2025
Profitability
Gross Margin 0.0%
FY 2019 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2019 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2019 5y median 0.0% FY 2025
ROE -28.7%
FY 2019 5y median -28.7% FY 2025
ROIC -21.3%
FY 2019 5y median -34.5% FY 2025
ROA -19.7%
FY 2019 5y median -24.8% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2019 FY 2025
Operating Income 37.8%
FY 2019 FY 2025
EPS (diluted) 32.7%
FY 2019 FY 2025
Free Cash Flow -10.1%
FY 2019 FY 2025
Financial Health
Current Ratio 14.2×
FY 2019 5y median 14.2× FY 2025
Quick Ratio 14.2×
FY 2019 5y median 14.2× FY 2025
Debt / Equity 0.3×
FY 2019 5y median 0.0× FY 2025
Net Debt / EBITDA -0.4×
FY 2019 5y median 0.5× FY 2025
Interest Coverage -16.5×
FY 2019 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2019 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2019 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31
